Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Return on Sales (2016 - 2025)

GeoVax Labs' Return on Sales history spans 15 years, with the latest figure at 8.62% for Q4 2025.

  • Quarterly results put Return on Sales at 8.62% for Q4 2025, up 94.0% from a year ago — trailing twelve months through Dec 2025 was 8.62% (down 230.0% YoY), and the annual figure for FY2025 was 8.62%, down 230.0%.
  • Return on Sales for Q4 2025 was 8.62% at GeoVax Labs, down from 7.55% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.08% in Q3 2024 to a low of 171.98% in Q4 2022.
  • The 4-year median for Return on Sales is 16.84% (2024), against an average of 40.04%.
  • The sharpest move saw Return on Sales tumbled -8867bps in 2022, then soared 1054bps in 2025.
  • Year by year, Return on Sales stood at 83.31% in 2021, then plummeted by -106bps to 171.98% in 2022, then skyrocketed by 94bps to 9.56% in 2024, then increased by 10bps to 8.62% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 8.62%, 7.55%, and 6.3% for Q4 2025, Q3 2025, and Q2 2025 respectively.